Elizabeth Holmes' lies were 'callous' and 'criminal,' the prosecution says

The government concluded months of testimony with an argument that Holmes made the deliberate choice to lie to investors and patients about her blood-testing startup’s difficulties.

Elizabeth Holmes

Elizabeth Holmes faces 11 counts of wire fraud and conspiracy to commit fraud against both investors and patients.

Photo: David Paul Morris/Bloomberg via Getty Images

Elizabeth Holmes had a choice.

That’s what Assistant U.S. Attorney Jeff Schenk argued in a federal courthouse in San Jose Thursday as the government’s fraud case against the former Theranos CEO drew to a close.

In closing arguments, Schenk said Holmes could have pitched investors the honest truth about Theranos: that it was never validated by pharmaceutical companies. That its devices were never used in medevacs or on the battlefield in Afghanistan. That its relationship with Walgreens was not healthy. That Theranos’ technology could only do a handful of tests after 10 years. That Theranos used modified third-party devices for most of its tests.

If she’d told patients the truth, Holmes would have had to admit that the tests that Theranos ran on its own devices often failed quality control checks, the prosecution argued. That it often took a venous draw, rather than a finger prick stick with a few drops, to get the blood.

Instead, the government claimed, Holmes made a choice to lie to investors and patients, a decision that was “not only callous, but also criminal,” Schenk told the jury.

The prosecution’s swan song capped testimony from 29 witnesses spanning four months. Holmes faces 11 counts of wire fraud and conspiracy to commit fraud against both investors and patients.

The government’s arguments focused on the idea that Holmes knew there were problems at the company and chose not to disclose them. Instead, Holmes’ role in the “scheme,” as the government alleges, was to keep the company alive by seeking infusions of funds, whether that was by attracting paying patients or continuing to recruit new investors.

Much of Holmes’ defense has been to point the finger at former Theranos COO Sunny Balwani, a trusted adviser and her long-term boyfriend who she says misled her. But the prosecution argued that the two worked in concert in a scheme to defraud.

Holmes’ role was to recruit investors and deliver false statements to them, whether it was directly through investor presentation or using articles in the media, like a Fortune magazine cover, Schenk said. Balwani’s alleged role was to run the lab and help deliver the investor presentations and false statements. These weren’t siloed responsibilities, the government contended, as it sought to show Holmes and Balwani keeping each other in the loop, often forwarding emails to each other when problems arose and deciding how to respond together.

Some moves were also entirely Holmes'. She admitted that she had added Pfizer’s logo to a report prepared by Theranos about their technology for the pharmaceutical company, and she did a similar move for a report featuring a Schering-Plough logo. When she sent the reports to Walgreens, she characterized them as “independent due diligence reports.”

The prosecution also replayed several audio clips to show that it was Holmes, and not Balwani, who tried to mislead the public. For example, in an interview, Fortune reporter Roger Parloff repeatedly asked why some patients would have had to do a venous blood draw instead of a finger prick at the Walgreens testing locations. Holmes’ excuse was that it was a scaling issue, or a problem of success — that Theranos had too many blood draws coming in so it was more efficient to collect using one larger container. The reality inside the lab was that Theranos could only run a handful of tests using the finger prick samples, Schenk said.

When it came to misleading patients, the government argued that the company’s advertising promising “faster,” “cheaper” and “more accurate” results was misleading, particularly around the issues of accuracy. Whistleblower Erika Cheung had described some of the quality control tests as “flipping a coin” on whether or not it would work. Theranos’ former lab director Adam Rosendorff had testified that the company “valued PR and fundraising over patient care” and that he’d raised concerns before the company launched in Walgreens.

The government also spent time trying to rebut arguments from the defense. On Holmes’ inexperience — she dropped out from Stanford to start Theranos — Schenk pointed out she had been running Theranos for nearly a decade and was closer to 30. And on the idea that many startups fail and failure is not a crime, he argued that Holmes lied because she didn’t want it to fail.

Schenk also praised witnesses who acted as whistleblowers, reporting Theranos’ actions to regulators and reporters like the Wall Street Journal’s John Carreyrou.

“The story of Theranos is in some ways a tragedy, but it is also a story of some people acting with remarkable integrity,” Schenk said, highlighting how employees like Cheung and Rosendorff spoke out.

One of the original Theranos whistleblowers, Tyler Shultz, watched the proceedings from the overflow room Thursday.


Judge Zia Faruqui is trying to teach you crypto, one ‘SNL’ reference at a time

His decisions on major cryptocurrency cases have quoted "The Big Lebowski," "SNL," and "Dr. Strangelove." That’s because he wants you — yes, you — to read them.

The ways Zia Faruqui (right) has weighed on cases that have come before him can give lawyers clues as to what legal frameworks will pass muster.

Photo: Carolyn Van Houten/The Washington Post via Getty Images

“Cryptocurrency and related software analytics tools are ‘The wave of the future, Dude. One hundred percent electronic.’”

That’s not a quote from "The Big Lebowski" — at least, not directly. It’s a quote from a Washington, D.C., district court memorandum opinion on the role cryptocurrency analytics tools can play in government investigations. The author is Magistrate Judge Zia Faruqui.

Keep ReadingShow less
Veronica Irwin

Veronica Irwin (@vronirwin) is a San Francisco-based reporter at Protocol covering fintech. Previously she was at the San Francisco Examiner, covering tech from a hyper-local angle. Before that, her byline was featured in SF Weekly, The Nation, Techworker, Ms. Magazine and The Frisc.

The financial technology transformation is driving competition, creating consumer choice, and shaping the future of finance. Hear from seven fintech leaders who are reshaping the future of finance, and join the inaugural Financial Technology Association Fintech Summit to learn more.

Keep ReadingShow less
The Financial Technology Association (FTA) represents industry leaders shaping the future of finance. We champion the power of technology-centered financial services and advocate for the modernization of financial regulation to support inclusion and responsible innovation.

AWS CEO: The cloud isn’t just about technology

As AWS preps for its annual re:Invent conference, Adam Selipsky talks product strategy, support for hybrid environments, and the value of the cloud in uncertain economic times.

Photo: Noah Berger/Getty Images for Amazon Web Services

AWS is gearing up for re:Invent, its annual cloud computing conference where announcements this year are expected to focus on its end-to-end data strategy and delivering new industry-specific services.

It will be the second re:Invent with CEO Adam Selipsky as leader of the industry’s largest cloud provider after his return last year to AWS from data visualization company Tableau Software.

Keep ReadingShow less
Donna Goodison

Donna Goodison (@dgoodison) is Protocol's senior reporter focusing on enterprise infrastructure technology, from the 'Big 3' cloud computing providers to data centers. She previously covered the public cloud at CRN after 15 years as a business reporter for the Boston Herald. Based in Massachusetts, she also has worked as a Boston Globe freelancer, business reporter at the Boston Business Journal and real estate reporter at Banker & Tradesman after toiling at weekly newspapers.

Image: Protocol

We launched Protocol in February 2020 to cover the evolving power center of tech. It is with deep sadness that just under three years later, we are winding down the publication.

As of today, we will not publish any more stories. All of our newsletters, apart from our flagship, Source Code, will no longer be sent. Source Code will be published and sent for the next few weeks, but it will also close down in December.

Keep ReadingShow less
Bennett Richardson

Bennett Richardson ( @bennettrich) is the president of Protocol. Prior to joining Protocol in 2019, Bennett was executive director of global strategic partnerships at POLITICO, where he led strategic growth efforts including POLITICO's European expansion in Brussels and POLITICO's creative agency POLITICO Focus during his six years with the company. Prior to POLITICO, Bennett was co-founder and CMO of Hinge, the mobile dating company recently acquired by Match Group. Bennett began his career in digital and social brand marketing working with major brands across tech, energy, and health care at leading marketing and communications agencies including Edelman and GMMB. Bennett is originally from Portland, Maine, and received his bachelor's degree from Colgate University.


Why large enterprises struggle to find suitable platforms for MLops

As companies expand their use of AI beyond running just a few machine learning models, and as larger enterprises go from deploying hundreds of models to thousands and even millions of models, ML practitioners say that they have yet to find what they need from prepackaged MLops systems.

As companies expand their use of AI beyond running just a few machine learning models, ML practitioners say that they have yet to find what they need from prepackaged MLops systems.

Photo: artpartner-images via Getty Images

On any given day, Lily AI runs hundreds of machine learning models using computer vision and natural language processing that are customized for its retail and ecommerce clients to make website product recommendations, forecast demand, and plan merchandising. But this spring when the company was in the market for a machine learning operations platform to manage its expanding model roster, it wasn’t easy to find a suitable off-the-shelf system that could handle such a large number of models in deployment while also meeting other criteria.

Some MLops platforms are not well-suited for maintaining even more than 10 machine learning models when it comes to keeping track of data, navigating their user interfaces, or reporting capabilities, Matthew Nokleby, machine learning manager for Lily AI’s product intelligence team, told Protocol earlier this year. “The duct tape starts to show,” he said.

Keep ReadingShow less
Kate Kaye

Kate Kaye is an award-winning multimedia reporter digging deep and telling print, digital and audio stories. She covers AI and data for Protocol. Her reporting on AI and tech ethics issues has been published in OneZero, Fast Company, MIT Technology Review, CityLab, Ad Age and Digiday and heard on NPR. Kate is the creator of RedTailMedia.org and is the author of "Campaign '08: A Turning Point for Digital Media," a book about how the 2008 presidential campaigns used digital media and data.

Latest Stories